Pricing

Log inSign up

Apogee Therapeutics

1 follower

‌

Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.

Industries

Biotechnology

Headquarters

San Francisco, United States

Employees

11-50

Links

Org chart

Michael Henderson
Chief Executive Officer at Apogee Therapeutics

Michael Henderson

Collapse
Carl Dambkowski
Chief Medical Officer
Dan Mulreany
Senior Vice President, Business Development and Strategy
Drew Badger
Senior Vice-President, Regulatory Affairs & Toxicology
Emily K Cox
Vp, Head Of People
Jane Pritchett Henderson
Chief Financial Officer
Wendy Aspden-Curran
Senior Vice President, Clinical Operations
JA
Jordan Adajar
Director, Regulatory Affairs
Mehrak Kiankarimi
Senior Vice President, Operations and Program Management
KN
Kristine Nograles
SVP, Clinical Development
NS
Nimish Shah
Co-Founder and Board Director
EW
Elizabeth W.
Senior Vice President, Quality Assurance
Tim Piringer
Senior Vice President, IT
Lukas Dillinger
Vice President, Research and Translational Medicine
Rebecca Dabora, PhD
Chief Technical Officer
Jeff Hartness
Chief Commercial Officer

Teams

+12

Leadership Team

15 members

+2

Clinical Operations and Development

5 members

+1

People and Talent Team

4 members

Business and Strategy

3 members

EW
JA

Regulatory Affairs and Quality Assurance Team

3 members

Similar companies

Caribou Biosciences

1 follower

10X Genomics

13 followers

Charles River Laboratories

10 followers

Amyris

8 followers

SpringWorks Therapeutics

5 followers

Omeros

4 followers

Arrowhead Pharmaceuticals

4 followers

Cerus

2 followers

ImmunityBio

2 followers

Amgen

198 followers

SCIEX

1 follower

Explore companies